Abstract:NADPH oxidase (NOX) has been shown to play a critical role in the development of cardiac hypertrophy induced by angiotensin II and α1-adrenergic receptor (AR) stimulation. Overexpression of a V204A DN mutant of NOX cytosolic subunit p67phox (DN-p67) was reported to prevent NOX-mediated superoxide generation in vitro. Recently, we found that overexpression of the DN-p67 mutant attenuated α1-AR-induced hypertrophy in cultured cardiac myocytes. In order to further investigate the role of NOX/67phox in cardiac hypertrophy in vivo, we generated a Tg mouse model with cardiac-specific overexpression of the above V204A DN-p67 coding region. For the convenience of transgene screening, an enhanced green fluorescent protein (EGFP) gene was linked downstream to the DN-p67 transgene. The independent translation of the EGFP was initiated by a leading viral sequence for internal ribosome entry site (IRES) that was linked to the 3'end of DN-p67. The DN-p67-IRES-EGFP transgene was next linked to the 3'end of a cardiac-specific a-MHC promoter generating a 9.1-Kb transgene that contains the α-MHC promoter, the DN-p67 coding region, the IRES-EGFP sequence, and a polyadenylation signal sequence. This new transgene was then injected into fertilized C57BL/6J zygotes that were transplanted into pseudopregnant mice. The obtained offspring mice were screened for transgene integration by PCR analysis and Southern blotting of tail DNA. Two pairs of PCR primers were used in screening to detect either a 640-bp EGFP coding sequence or a 277-bp region span the junction between the α-MHC promoter and the DN-p67 coding sequence. Three Tg-positive founder mice (2 male and 1 female) were obtained. Currently, at age of 18 weeks, the 3 founder mice are all viable and healthy with normal phenotypes. At age of 10 weeks, each of the 3 founders was bred to wild type (WT) C57BL/6J mice independently, and had produced 6 DN-p67 Tg offspring at present. These heterozygous Tg littermates will be used to independently breed for homozygous DN-p67 Tg lines derived from each of the 3 Tg founders. In summary, we have generated a Tg mouse model with cardiac-specific overexpression of a DN mutant of p67phox, which would be a useful in vivo model for studying cardiac diseases involving NOX/p67phox.

[Construction of Runx1 Transgenic Mice].

Development of Transgenic Mouse Model Containing Xyle Target Gene

[Construction of Expression Vector Plck-Cd69-ires-egfp and Generation of CD69 Transgenic Mice].

Construction of Animal Model of Transgenic Mice Expressing Human Insulin

Construction and identification of the recombinant lentiviral vector containing human Runx3 gene

Animal Model for Heterologous Transplantation-Generating of Transgenic Mice That Expresses Hcd59 Cdna

[Construct Mxi1 Mutation Gene Expression Vector from Leukemia Cell Line KG1].

Generation and Characterization of Transgenic Mice Expressing Mouse Ins1 Promoter for Pancreatic Β-Cell-specific Gene Overexpression and Knockout.

Emx1-Specific Expression of Foreign Genes Using “Knock-In” Approach

Establishment of a Dlx2 conditional activation transgenic mouse model

Construction and Tissue Specific Expression of Cre Transgenic Mice

Construction of a Mouse Novel Gene Targeting Vector and Recombination Screening

Generation of a Transgenic (tg) Mouse Model with Cardiac Specific Overexpression of a Dominant Negative (DN) Mutant of P67phox

Establishment of Transgenic Mice Carrying Gene Encoding Human Zinc Finger Protein 191

Production of Human CD59 Cdna Transgenic Founder Mice--an Animal Model for Xenotransplantation

Establishment of transgenic mice for HRX-EEN fusion gene

Establishment and Phenotypic Analysis in Transgenic Mice with AML1-ETO Fusion Gene

Highly efficient Runx1 enhancer eR1-mediated genetic engineering for fetal, child and adult hematopoietic stem cells

The Construction of a Cre Recombinase Expression Vector That Targets the Expression of Cre in Pancreas of Transgenic Mouse

A novel mouse model carrying a gene trap insertion into the Hmgxb4 gene locus to examine Hmgxb4 expression in vivo

Construction of ACTA2 mutation transgenic mice